Teva's Planned Generic Infringes Mylan Patents, Judge Says
A West Virginia federal judge ruled Friday that claims asserted by Mylan Inc. in a patent-infringement suit over Teva Pharmaceutical USA Inc.'s planned generic version of Mylan's respiratory illness drug Perforomist...To view the full article, register now.
Already a subscriber? Click here to view full article